AGL 8.00 Decreased By ▼ -0.15 (-1.84%)
ANL 11.32 Increased By ▲ 0.23 (2.07%)
AVN 83.45 Decreased By ▼ -0.25 (-0.3%)
BOP 5.85 No Change ▼ 0.00 (0%)
CNERGY 5.85 Increased By ▲ 0.20 (3.54%)
EFERT 80.10 Decreased By ▼ -0.12 (-0.15%)
EPCL 67.29 Increased By ▲ 0.01 (0.01%)
FCCL 15.20 No Change ▼ 0.00 (0%)
FFL 7.04 Decreased By ▼ -0.19 (-2.63%)
FLYNG 7.77 Decreased By ▼ -0.29 (-3.6%)
GGGL 11.90 Decreased By ▼ -0.10 (-0.83%)
GGL 17.65 Decreased By ▼ -0.06 (-0.34%)
GTECH 9.18 Increased By ▲ 0.40 (4.56%)
HUMNL 7.20 Decreased By ▼ -0.03 (-0.41%)
KEL 3.50 Decreased By ▼ -0.24 (-6.42%)
LOTCHEM 30.95 Decreased By ▼ -1.15 (-3.58%)
MLCF 28.52 Decreased By ▼ -0.48 (-1.66%)
OGDC 85.20 Decreased By ▼ -0.85 (-0.99%)
PAEL 17.11 Decreased By ▼ -0.29 (-1.67%)
PIBTL 6.15 Decreased By ▼ -0.15 (-2.38%)
PRL 19.84 Increased By ▲ 0.74 (3.87%)
SILK 1.29 Increased By ▲ 0.10 (8.4%)
TELE 12.05 Decreased By ▼ -0.20 (-1.63%)
TPL 9.16 Decreased By ▼ -0.02 (-0.22%)
TPLP 20.19 Decreased By ▼ -0.51 (-2.46%)
TREET 27.10 Increased By ▲ 0.15 (0.56%)
TRG 97.30 Decreased By ▼ -0.45 (-0.46%)
UNITY 22.83 Decreased By ▼ -0.17 (-0.74%)
WAVES 13.29 Decreased By ▼ -0.81 (-5.74%)
WTL 1.45 Increased By ▲ 0.14 (10.69%)
BR100 4,361 Decreased By -27.2 (-0.62%)
BR30 16,009 Decreased By -90.5 (-0.56%)
KSE100 43,482 Decreased By -195.1 (-0.45%)
KSE30 16,476 Decreased By -56.6 (-0.34%)
World

New Zealand to buy enough Pfizer COVID-19 vaccines for entire population

  • New Zealand started its national rollout of the Pfizer-BioNTech's COVID-19 vaccine last month and expects to inoculate its entire population by the end of the year.
Published March 8, 2021

SYDNEY: New Zealand will buy additional COVID-19 vaccines, developed by Pfizer Inc and Germany's BioNTech, which will be enough to vaccinate the whole country, Prime Minister Jacinda Ardern said on Monday.

The government has signed an agreement to buy an extra 8.5 million doses, enough to vaccinate over 4 million people, Ardern said, adding the vaccines were expected to reach the country in the second half of the year.

"This brings our total Pfizer order to 10 million doses or enough for 5 million people to get the two shots needed to be fully vaccinated against COVID-19," Ardern said in a statement.

The government's original agreement with Pfizer was for 1.5 million doses, enough to vaccinate 750,000 people.

Ardern said the decision to make Pfizer the country's primary vaccine provider was taken after it was shown to be about 95% effective at preventing symptomatic infection.

New Zealand started its national rollout of the Pfizer-BioNTech's COVID-19 vaccine last month and expects to inoculate its entire population by the end of the year.

With just over 2,000 confirmed COVID-19 cases and 26 deaths, New Zealand largely contained the pandemic compared with other developed countries, helped by speedy tracking systems, border closures and snap lockdowns.

Auckland, New Zealand's biggest city, emerged on Sunday from a strict week long lockdown imposed after a community cluster of the more contagious British coronavirus variant. It reported no new cases on Monday.

Comments

Comments are closed.